Welch Allyn and Inovise Medical Announce Technology Agreement

Partnership supports the overall business strategies of both companies

SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn, a leading global manufacturer of frontline medical products and solutions announced today that it has entered into a multi-year agreement with Inovise Medical, Inc., a privately held cardiac technology company. Under terms of the agreement, Welch Allyn will license Inovise Medical, Inc.’s AUDICOR® technology with improved cardiac information to accurately diagnose more patients with acute or previous silent heart attacks at the point of care.

“This partnership supports the overall business strategies of both companies and strengthens our mutual abilities to provide frontline caregivers with innovative solutions to patient care problems.”

“Integrating the Audicor® advanced electrocardiograph (ECG) analysis capability into our future line of cardiology products is an indication of our commitment to providing clinicians with the most advanced diagnostic capabilities to enhance patient care and improve outcomes,” said Julie Shimer, president and chief executive officer at Welch Allyn. “This partnership supports the overall business strategies of both companies and strengthens our mutual abilities to provide frontline caregivers with innovative solutions to patient care problems.”

Inovise Medical’s AUDICOR^® technology identifies subtle ECG features in patients that often present with atypical changes, such as those in female patients and patients with confounding conditions.

Peter Bauer, president of Inovise Medical, added, “Inovise’s AUDICOR^® technology was developed through years of focused research and algorithm development. We are pleased that through Welch Allyn’s successful products, more patients and clinicians will benefit from earlier diagnosis and treatment in the near future.”

About Inovise Medical

Inovise Medical, Inc., of Portland, Oregon is a privately held company founded in 1997 focused on advanced cardiac technology. Inovise Medical's technology includes advanced ECG algorithms for improved MI detection and AUDICOR^® which evaluates the performance of the heart through analyzing heart sounds and cardiac timing intervals. AUDICOR^® enables clinicians to non-invasively and rapidly assess cardiac patients to aid in early diagnosis and or to adjust treatment. AUDICOR results have been published in over 40 peer-reviewed scientific journal articles. AUDICOR technology is used both in EMS and hospitals for diagnostics and in clinics for evaluating the correct setting of internal pacing devices. Additional information on Inovise Medical, Inc. and AUDICOR^® technology may be found at http://www.audicor.com

About Welch Allyn

Founded in 1915 and headquartered in Skaneateles Falls, NY (USA), Welch Allyn is a leading global manufacturer of medical diagnostic equipment and a complete range of digital and connected solutions. With 2,600 employees working in 26 different countries, Welch Allyn specializes in helping doctors, nurses, and other frontline practitioners across the globe provide the best patient care by developing innovative products, breakthrough technologies, and cutting-edge solutions that help them see more patients, detect more conditions, and improve more lives. More information about Welch Allyn and its complete line of connected products and solutions may be found at www.welchallyn.com.